Study finds gender disparities on National Institutes of Health study sections

February 15, 2021

Investigators at the University of Chicago Medicine have found that women are less likely to be represented as chairs and reviewers on study sections for the National Institutes of Health (NIH), based on data from one review cycle in 2019. The results, published on Feb. 15 in JAMA Network Open, have implications for the distribution of federal scientific funding.

The NIH is the top source of federal funding for biomedical research in the U.S., providing critical support and guidance on the nation's research programs. The study sought to understand the gender distribution on NIH study sections, where scientific experts meet several times per year to discuss grant applications and determine what research will receive NIH funding.

The investigators pulled the digital rosters for all study sections that met between May 15 and July 15 in 2019 - a total of 367 study sections. Then, they used online searches to find photos and/or pronouns for all ~8800 individuals on the study section rosters to determine gender identity. For the 23 individuals whose genders could not be ascertained, the researchers used the software to provide a best estimate on the person's gender.

The analysis determined that overall the balance of reviewers was tipped toward men (61.1% of reviewers, versus 38.9% women). Further, women were more likely to hold lower academic rank and were more likely to be temporary members and less likely to be on standing study sections.

"The results were not surprising," said first author Anna Volerman, MD, an assistant professor of medicine and pediatrics at UChicago Medicine. "Men are more likely to serve on study sections, both as members of the section and as chairs; women were more likely to have a temporary affiliation. There was also a lower chance of having women participating on study sections for institutes that had greater funding resources and gave out more awards.

"The message is clear: there are disparities in gender representation on these study sections, which have the potential to impact the funding and advancement of women in research," Volerman continued. "This affects our whole country, because we know that the people conducting the research affect the scientific questions being asked and answered."

While this study only used data from one review cycle, the research team hopes to further investigate this trend, as well as examine data on other demographic information, such as race. They acknowledge that this study uses limited data, and restricts gender to a male/female binary.

"This is a snapshot," said senior author Valerie Press, MD, MPH, an associate professor of medicine and pediatrics at UChicago Medicine. "It is important to look backward in order to look forward. Diversity, inclusion and equity are a process, not a switch that gets flipped. It is likely that despite the disparities we see, there has been improvement over time. Establishing that will be helpful for motivating the actions needed to have a more representative cohort of members of these sections."

The researchers also plan to examine the relationship between gender representation on study sections and the gender breakdown in who receives NIH funding. They hope that this study, and others like it, will further clarify the existing disparities in gender representation in biomedical research and provide additional insights into how those disparities are best addressed.

"This is a first step," said Volerman. "This study provides a glimpse that will help us better understand this issue and then use deliberate efforts to work toward achieving equitable representation at all career levels."
The study, "Representation of Women on National Institutes of Health Study Sections," was supported by the University of Chicago Diversity Research and Small Grant Program. Additional authors include Vineet Arora, John Cursio, and Helen Wei of the University of Chicago.

About the University of Chicago Medicine & Biological Sciences

The University of Chicago Medicine, with a history dating back to 1927, is one of the nation's leading academic health systems. It unites the missions of the University of Chicago Medical Center, Pritzker School of Medicine and the Biological Sciences Division. Twelve Nobel Prize winners in physiology or medicine have been affiliated with the University of Chicago Medicine. Its main Hyde Park campus is home to the Center for Care and Discovery, Bernard Mitchell Hospital, Comer Children's Hospital and the Duchossois Center for Advanced Medicine. It also has ambulatory facilities in Orland Park, South Loop and River East as well as affiliations and partnerships that create a regional network of care. UChicago Medicine offers a full range of specialty-care services for adults and children through more than 40 institutes and centers including an NCI-designated Comprehensive Cancer Center. Together with Harvey-based Ingalls Memorial, UChicago Medicine has 1,296 licensed beds, nearly 1,300 attending physicians, over 2,800 nurses and about 970 residents and fellows.

Visit UChicago Medicine's health and science news blog at

Twitter @UChicagoMed

University of Chicago Medical Center

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to